Motley Fool39d agobullish
Iovance Biotherapeutics Stock Soars After the Company Posts Strong Q2 Earnings. Is It Heading Even Higher?The healthcare stock is now up more than 130% this year.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
60last 24h
975last 7d
109● bullish (7d)
123● bearish (7d)
212publishers